清肺化痰方联合阿奇霉素治疗儿童支原体肺炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563.1+5

基金项目:


Clinical Study on Qingfei Huatan Prescription Combined with Azithromycin for Mycoplasma Pneumonia in Children
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清肺化痰方联合阿奇霉素治疗儿童支原体肺炎的临床疗效。方法:将105 例支原体肺炎患儿按随机数字表法分为治疗组65 例与对照组40 例。2 组入院后均给予常规对症治疗,对照组加用阿奇霉素治疗,治疗组在对照组的基础上加用清肺化痰方治疗。治疗3 周后评估2 组临床疗效、中医证候积分、肺功能指标[用力肺活量(FVC)、第1 秒用力呼气量(FEV1)、FEV1/FVC]、血清炎症因子[白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)、C-反应蛋白(CRP)]水平。结果:治疗组治疗总有效率为93.85%,对照组为80.00%,2 组比较,差异有统计学意义(P<0.05)。治疗前,2 组中医证候积分比较,差异无统计学意义(P>0.05);治疗后,2 组中医证候积分均较治疗前降低(P<0.05),且治疗组中医证候积分低于对照组(P<0.05)。治疗前,2 组FVC、FEV1、FEV1/FVC 水平比较,差异无统计学意义(P>0.05);治疗后,2 组上述肺功能指标均较治疗前明显升高(P<0.05),且治疗组各项指标均高于对照组(P<0.05)。治疗前,2 组血清IL-6、IL-8、TNF-α、CRP 水平比较,差异无统计学意义(P>0.05);治疗后,2 组上述各项炎症因子水平均较治疗前明显降低(P<0.05),且治疗组各项指标均低于对照组(P<0.05)。结论:清肺化痰方联合阿奇霉素治疗支原体肺炎患儿疗效肯定,可显著缓解患儿临床症状,改善肺功能和炎症反应,疗效优于单用阿奇霉素治疗。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Qingfei Huatan prescription combined with azithromycin for mycoplasma pneumonia in children. Methods:A total of 105 cases of children with mycoplasma pneumonia were divided into the treatment group and the control group according to the random number table method,with 65 and 40 cases in each group respectively. After admission, both groups were given routine symptomatic treatment; the control group was additionally treated with azithromycin,and the treatment group was additionally treated with Qingfei Huatan prescription based on the treatment of the control group. After three weeks of treatment,clinical effects,Chinese medicine syndrome scores,lung function indexes including forced vital capacity(FVC),forced expiratory volume in one second(FEV1) and FEV1/FVC,as well as the levels of serum inflammatory factors including interleukin-6(IL-6),interleukin-8(IL-8)),tumor necrosis factor-α(TNF-α) and C-reactive protein(CRP) in the two groups were evaluated. Results:The total curative effective rate was 93.85% in the treatment group and 80.00% in the control group,the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of Chinese medicine syndrome scores between the two groups(P>0.05). After treatment,Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment(P<0.05), and the score in the treatment group was lower than that in the control group(P<0.05). Before treatment, there was no significant difference being found in the comparison of the levels of FVC, FEV1 and FEV1/FVC between the two groups(P>0.05). After treatment,the above indexes of lung function in the two groups were significantly increased when compared with those before treatment(P<0.05),and the above indexes in the treatment group were higher than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of the levels of IL- 6,IL- 8,TNF- α and CRP between the two groups(P>0.05);after treatment,the levels of the above inflammatory factors in the two groups were significantly decreased when compared with those before treatment(P<0.05), and the above indexes in the treatment group were lower than those in the control group(P<0.05). Conclusion:The therapy of Qingfei Huatan prescription combined with azithromycin for mycoplasma pneumonia in children has a definite curative effect, and can significantly relieve their clinical symptoms, improve lung function and inflammatory responses. It has a better curative effect than simple azithromycin.

    参考文献
    相似文献
    引证文献
引用本文

苏小燕,史晓霞,阮仙利.清肺化痰方联合阿奇霉素治疗儿童支原体肺炎临床研究[J].新中医,2022,54(8):124-128

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-04-24
  • 出版日期:
文章二维码